At a Glance
Spero Ventures was founded in 2016 by Nan Li and Kevin Zhang, bringing a unique combination of investment and operational expertise to seed-stage investing. The firm distinguishes itself through a highly analytical, data-driven approach to identifying and evaluating early-stage opportunities across enterprise software, fintech, and healthcare technology. Spero's founding partners previously held leadership roles at prominent technology companies and investment firms, giving them deep insights into what drives category-creating companies. The firm focuses on partnering with exceptional entrepreneurs who are building transformative solutions to large market opportunities. Spero is known for its rigorous due diligence process and its ability to provide strategic guidance to help portfolio companies achieve product-market fit and scale efficiently. The firm has built a reputation for identifying breakout companies early, with several portfolio companies achieving significant valuations and market leadership positions. Their hands-on approach includes helping founders with go-to-market strategy, talent acquisition, and strategic partnerships.
“Investing in category-creating companies with exceptional entrepreneurs and strong market potential.”
Spero Ventures primarily invests at the Seed, Series A stages. This means they focus on companies that are building their initial product and finding product-market fit.
Spero Ventures is headquartered in San Francisco, CA. Many of their portfolio companies are also based in this region, though they invest across geographies.
Spero Ventures focuses on investments in Enterprise, Fintech, Digital Health. Their portfolio reflects deep expertise and networks within these sectors.
Spero Ventures's typical investment check size ranges from $500K to $2M. Actual amounts may vary based on the stage, sector, and specific opportunity.
Spero Ventures manages approximately $30M in assets under management (AUM) across their funds.
